Infarct volume predicts early neurological deterioration after endovascular stroke treatment
A retrospective cohort study analyzed 682 ischemic stroke patients who underwent endovascular treatment (EVT) to examine predictors of early neurological deterioration (END), defined as a National Institutes of Health Stroke Scale (NIHSS) increase of ≥4 points within 24 hours post-procedure. The study did not report a comparator group, specific setting, or detailed patient characteristics beyond the procedure and outcome definition. The primary finding was that 208 patients (30.5%) developed END. Infarct volume was identified as an independent predictor for overall END, with an area under the curve (AUC) of 0.768. For the secondary outcomes, infarct volume showed predictive value for non-hemorrhagic END (AUC = 0.682) and particularly strong predictive value for hemorrhagic END (AUC = 0.825). An optimal infarct volume threshold of 35.5 mL was reported for predicting END. Safety and tolerability data were not reported. The key limitation is the retrospective study design, which can introduce bias and limits causal inference. The funding source and potential conflicts of interest were not reported. The practice relevance is restrained; the findings suggest an association where incorporating infarct volume into postoperative assessment may help flag patients at higher risk for deterioration, but this requires prospective validation.